Literature DB >> 4061491

Familial hypercholesterolemia with "normal" cholesterol in obligate heterozygotes.

J J Nora, R M Lortscher, R D Spangler, D W Bilheimer.   

Abstract

We have investigated the family of a 15-year-old proposita with a homozygous, receptor-defective, familial hypercholesterolemia and found that her consanguineous, obligate heterozygous parents have "normal" cholesterol levels and a family history of unusual longevity. Documentation of paternity and the presence of the heterozygous biochemical disorder in the parents is firm. The implications are that, at least in this family, relatively low serum cholesterol and high levels of HDL cholesterol are protective against the risks associated with having a mutant allele for heterozygous familial hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061491     DOI: 10.1002/ajmg.1320220317

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia.

Authors:  Akl C Fahed; Fadi F Bitar; Ruby I Khalaf; Elie M Moubarak; Sami T Azar; Georges M Nemer
Journal:  Endocrine       Date:  2012-04-10       Impact factor: 3.633

2.  A cholesterol-lowering gene maps to chromosome 13q.

Authors:  H Knoblauch; B Müller-Myhsok; A Busjahn; L Ben Avi; S Bähring; H Baron; S C Heath; R Uhlmann; H D Faulhaber; S Shpitzen; A Aydin; A Reshef; M Rosenthal; O Eliav; A Mühl; A Lowe; D Schurr; D Harats; E Jeschke; Y Friedlander; H Schuster; F C Luft; E Leitersdorf
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia.

Authors:  G L Vega; S M Grundy
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

4.  European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia.

Authors:  H Schuster; S Humphries
Journal:  Clin Investig       Date:  1994-11

5.  Use of the single-strand conformational polymorphism method to detect recurrent and novel mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolaemia: detection of a novel mutation Asp200-->Gly.

Authors:  V Gudnason; Y T Mak; J Betteridge; S N McCarthy; S Humphries
Journal:  Clin Investig       Date:  1993-04

6.  Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.

Authors:  W K Lee; L Haddad; M J Macleod; A M Dorrance; D J Wilson; D Gaffney; M H Dominiczak; C J Packard; I N Day; S E Humphries; A F Dominiczak
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

7.  Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.

Authors:  K Widhalm; A Dirisamer; A Lindemayr; G Kostner
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.